Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13853001 | 0.96 | L3MBTL1 (0.44) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL13852973 | 0.83 | ALDH1A1 (0.38) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL18805392 | 0.72 | L3MBTL1 (0.40) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL10023035 | 0.72 | ALDH1A1 (0.60) | KMT2AKDM4EHPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL10023041 | 0.72 | ALDH1A1 (0.60) | KMT2AKDM4EHPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL31599316 | 0.71 | ALDH1A1 (0.56) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL30395001 | 0.71 | ALDH1A1 (0.56) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL24590007 | 0.70 | KDM4E (0.75) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL13726198 | 0.70 | KDM4E (0.75) | L3MBTL1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL19953862 | 0.69 | AKT1 (0.66) | KDM4EHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8449989-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2013-05-28 | — | — | US | disclosed |
| US-8449989-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2013-05-28 | — | — | US | disclosed |
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD (KR) | 2009-05-14 | — | — | US | disclosed |
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD (KR) | 2009-05-14 | — | — | US | disclosed |
| US-7455917-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2008-11-25 | — | — | US | disclosed |
| US-7455917-B2 | Organic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2008-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090121622-A1 | NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LEF1, CYBA, AOX1 | L3MBTL1 1076/4885MEN1 2307/4885KMT2A 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.